BridgeBio Oncology Therapeutics Statistics
NASDAQ: BBOTHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.81-0.05 (-2.69%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BridgeBio Oncology Therapeutics by the numbers
BridgeBio Oncology Therapeutics has a market capitalization of $145.3 million based on 80.25M shares outstanding. Its trailing P/E ratio is 3.4. The stock trades 42.3% below its 50-day average and 75.5% below its 200-day average.
Average daily trading volume is 631.56K shares, or about $1.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BBOT valuation vs. peer median
| Metric | BBOT | Peer median | Difference |
|---|---|---|---|
| Market cap | $145.25M | $148.17M | -2% |
| Avg. volume | 631.56K | 831.15K | -24% |
Peer median across 8 companies: PRQR, VRXA, RNA, ELDN, IFRX, ALXO, ORMP, ZNTL.
Valuation
- Market cap
- $145.25M
- P/E (TTM)
- 3.42
- EPS (TTM)
- $0.53
- Shares outstanding
- 80.25M
Price and trading
- Previous close
- 1.86
- Open
- 1.87
- Day range
- 1.79 – 1.94
- 52-week range
- 1.79 – 14.87
- 52-week change
- -85.39%
- Beta
- —
- Volume
- 450.96K
- Average volume
- 631.56K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 10, 2026
Additional statistics
- Market Cap
- 145.25M
- Pe
- 3.42
- Forward Pe
- -0.87
- Eps
- 0.53
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 14.87
- Week52 Low
- 1.79
- Avg Volume
- 631.56K
- Shares Outstanding
- 80.25M
- Ma50
- 3.14
- Ma200
- 7.40
- Earnings Date
- Nov 10, 2026
- Pct From52w High
- -87.83%
- Pct From52w Low
- 1.40%